Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Marco_Quarta
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:developedBy |
small molecule drugs
senolytic therapies |
| gptkbp:focusesOn |
aging
regenerative medicine senescent cell targeting |
| gptkbp:foundedYear |
2018
|
| gptkbp:founder |
gptkb:Marco_Quarta
|
| gptkbp:headquartersLocation |
gptkb:Sunnyvale,_California
|
| https://www.w3.org/2000/01/rdf-schema#label |
Rubedo Life Sciences
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:investor |
gptkb:Khosla_Ventures
gptkb:Longevitytech.fund gptkb:Refactor_Capital |
| gptkbp:mission |
to develop therapies for age-related diseases
|
| gptkbp:platform |
gptkb:ALEMBIC_drug_discovery_platform
|
| gptkbp:targetMarket |
age-related diseases
chronic diseases |
| gptkbp:website |
https://www.rubedolife.com/
|
| gptkbp:bfsParent |
gptkb:Laura_Deming
|
| gptkbp:bfsLayer |
6
|